story of the week
Trifluridine–Tipiracil and Bevacizumab for Refractory Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
N. Engl. J. Med 2023 May 04;388(18)1657-1667, GW Prager, J Taieb, M Fakih, F Ciardiello, E Van Cutsem, E Elez, FM Cruz, L Wyrwicz, D Stroyakovskiy, Z Pápai, PG Poureau, G Liposits, C Cremolini, I Bondarenko, DP Modest, KA Benhadji, N Amellal, C Leger, L Vidot, J TaberneroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.